S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
OTCMKTS:LUXTY

Luxottica Group (LUXTY) Stock Price, News & Analysis

$55.80
+0.20 (+0.36%)
(As of 03/22/2019)
Today's Range
$49.87
$55.90
50-Day Range
$55.80
$55.80
52-Week Range
$49.83
$69.03
Volume
2,900 shs
Average Volume
14,259 shs
Market Capitalization
$27.07 billion
P/E Ratio
24.37
Dividend Yield
1.63%
Price Target
N/A
LUXTY stock logo

About Luxottica Group Stock (OTCMKTS:LUXTY)

Luxottica Group S.p.A., together with its subsidiaries, provides fashion, luxury, sports, and performance eyewear worldwide. It operates through two segments, Manufacturing and Wholesale Distribution, and Retail Distribution. The Manufacturing and Wholesale Distribution segment engages in the design, manufacture, distribution, and marketing of proprietary and designer lines of prescription frames and sunglasses. This segment offers its products under proprietary brands, such as Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli, Arnette, and Vogue Eyewear; and licensed brands, including Giorgio Armani, Emporio Armani, Armani Exchange, Brooks Brothers, Burberry, Bulgari, Chanel, Coach, Dolce&Gabbana, DKNY, Michael Kors, Paul Smith Spectacles, Prada, Miu Miu, Ralph Lauren, Polo Ralph Lauren, Ralph, Starck Eyes, Tiffany & Co, Tory Burch, Valentino, Versace, and Ferrari. The Retail Distribution segment operates prescription eyewear stores primarily under its retail brands, including LensCrafters, Sunglass Hut, Pearle Vision, OPSM, Laubman & Pank, GMO, David Clulow, Salmoiraghi & Viganò, Ray-Ban, Oakley and Vault, Oliver Peoples, Alain Mikli, Ilori Optical, and Optical Shop of Aspen; and licensed brands, such as Sears Optical and Target Optical. As of December 31, 2017, it operated approximately 9,000 stores. The company was founded in 1961 and is headquartered in Milan, Italy. As of October 1, 2018, Luxottica Group S.p.A. operates as a subsidiary of EssilorLuxottica.

LUXTY Stock Price History

LUXTY Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
11 Sunglasses Brands to Try
Quiet Luxury is Out. Loud Budgeting is In.
Lucid: Why I'm Not Worried About The Cash Burn
15 of the youngest billionaires in the world today
See More Headlines
Receive LUXTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Luxottica Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/26/2015
Today
4/19/2024

Industry, Sector and Symbol

Industry
Ophthalmic Goods
Sub-Industry
N/A
Current Symbol
OTCMKTS:LUXTY
CIK
N/A
Fax
N/A
Employees
85,150
Year Founded
1961

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.34 billion
Cash Flow
$3.57 per share
Book Value
$13.74 per share

Miscellaneous

Free Float
N/A
Market Cap
$27.07 billion
Optionable
Not Optionable
Beta
0.27
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Dr. Leonardo Del Vecchio (Age 84)
    Founder & Exec. Chairman
  • Mr. Francesco Milleri (Age 60)
    Deputy Chairman & CEO
  • Mr. Luigi Francavilla (Age 82)
    Deputy Chairman
  • Mr. Stefano Grassi (Age 46)
    CFO & Exec. Director
  • Mr. Giorgio Striano (Age 48)
    Chief Operating Officer

Should I Buy Luxottica Group Stock? LUXTY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Luxottica Group SpA:

  • Luxottica Group SpA has shown consistent revenue growth over the past year, indicating a strong financial performance.
  • The company's recent strategic partnerships with high-end fashion brands have enhanced its brand value and market positioning.
  • With the increasing global demand for luxury eyewear, Luxottica is well-positioned to capitalize on this trend and drive future profitability.
  • Luxottica's focus on innovation and product quality, especially in its latest eyewear collections, ensures a competitive edge in the market.
  • The current stock price of Luxottica Group SpA reflects positive investor sentiment and growth potential in the luxury eyewear industry.

Cons

Investors should be bearish about investing in Luxottica Group SpA for these reasons:

  • The luxury retail sector, including high-end eyewear, is susceptible to economic downturns and fluctuations in consumer spending, posing a risk to Luxottica's revenue.
  • Intense competition in the luxury eyewear market from other established brands may impact Luxottica's market share and profitability.
  • Changes in consumer preferences and fashion trends could affect the demand for Luxottica's products, leading to potential sales challenges.
  • Foreign exchange rate fluctuations can impact Luxottica's international operations and financial performance, especially in regions with currency volatility.
  • Investors should closely monitor any regulatory changes or trade policies that could impact Luxottica's supply chain and manufacturing costs, affecting overall profitability.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, April 13, 2024. Please send any questions or comments about these Luxottica Group pros and cons to contact@marketbeat.com.

LUXTY Stock Analysis - Frequently Asked Questions

How have LUXTY shares performed in 2024?

Luxottica Group's stock was trading at $55.80 at the beginning of the year. Since then, LUXTY stock has increased by 0.0% and is now trading at $55.80.
View the best growth stocks for 2024 here
.

How were Luxottica Group's earnings last quarter?

Luxottica Group SpA (OTCMKTS:LUXTY) issued its quarterly earnings data on Monday, October, 26th. The company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.50 by $0.02. The business earned $2.40 billion during the quarter, compared to the consensus estimate of $2.50 billion.

Is Luxottica Group a good dividend stock?

Luxottica Group (OTCMKTS:LUXTY) pays an annual dividend of $0.91 per share and currently has a dividend yield of 1.63%. The dividend payout ratio is 39.74%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LUXTY.

How do I buy shares of Luxottica Group?

Shares of LUXTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LUXTY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners